List of Vedanta Biosciences patents

List of Vedanta Biosciences patents

List of Angus Chemical Company patents

List of Aimmune Therapeutics patents

List of NuoDB patents

List of companies in Draper Dragon's investment portfolio

List of funding rounds for AppDirect

Patents where

Current Assignee

Name

is

Vedanta Biosciences

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11447738 Methods and compositions for preserving bacteria		Vedanta Biosciences	Vedanta Biosciences		United States Patent and Trademark Office	11447738	September 20, 2022
	‌ US Patent 10555980 Treatment of	Patent 10555980 was granted and assigned to Vedanta Biosciences on February, 2020 by the United States Patent and Trademark Office.	Vedanta Biosciences	Vedanta Biosciences		United States Patent and Trademark Office	10555980	February 11, 2020
	‌ US Patent 10064904 Treatment of	Patent 10064904 was granted and assigned to Vedanta Biosciences on September, 2018 by the United States Patent and Trademark Office.	Vedanta Biosciences	Vedanta Biosciences		United States Patent and Trademark Office	10064904	September 4, 2018
	‌ US Patent 9999641 Treatment of clostridium difficile infection	Patent 9999641 was granted and assigned to Vedanta Biosciences on June, 2018 by the United States Patent and Trademark Office.	Vedanta Biosciences	Vedanta Biosciences		United States Patent and Trademark Office	9999641	June 19, 2018
	‌ US Patent 10507221 Compositions and methods for the treatment of allergy	Patent 10507221 was granted and assigned to Vedanta Biosciences on December, 2019 by the United States Patent and Trademark Office.	Vedanta Biosciences	Vedanta Biosciences		United States Patent and Trademark Office	10507221	December 17, 2019
	‌ US Patent 11000556 Compositions and methods for the treatment of allergy	Patent 11000556 was granted and assigned to Vedanta Biosciences on May, 2021 by the United States Patent and Trademark Office.	Vedanta Biosciences	Vedanta Biosciences		United States Patent and Trademark Office	11000556	May 11, 2021
	‌ US Patent 10350250 Treatment of clostridium difficile infection	Patent 10350250 was granted and assigned to Vedanta Biosciences on July, 2019 by the United States Patent and Trademark Office.	Vedanta Biosciences	Vedanta Biosciences		United States Patent and Trademark Office	10350250	July 16, 2019
	‌ US Patent 10456431 Treatment of clostridium difficile infection	Patent 10456431 was granted and assigned to Vedanta Biosciences on October, 2019 by the United States Patent and Trademark Office.	Vedanta Biosciences	Vedanta Biosciences		United States Patent and Trademark Office	10456431	October 29, 2019
	‌ US Patent 11701396 Treatment of		Vedanta Biosciences	Vedanta Biosciences		United States Patent and Trademark Office	11701396	July 18, 2023

9 results

0 selected

9 results

0 selected